[go: up one dir, main page]

DK0986393T3 - Anvendelse af et nitroxid eller et prodrug heraf ved profylaktisk og terapeutisk behandling af cancer - Google Patents

Anvendelse af et nitroxid eller et prodrug heraf ved profylaktisk og terapeutisk behandling af cancer

Info

Publication number
DK0986393T3
DK0986393T3 DK98923772T DK98923772T DK0986393T3 DK 0986393 T3 DK0986393 T3 DK 0986393T3 DK 98923772 T DK98923772 T DK 98923772T DK 98923772 T DK98923772 T DK 98923772T DK 0986393 T3 DK0986393 T3 DK 0986393T3
Authority
DK
Denmark
Prior art keywords
cancer
nitroxide
prodrug
prophylactic
therapeutic treatment
Prior art date
Application number
DK98923772T
Other languages
English (en)
Inventor
James B Mitchell
Angelo Russo
Anne Marie Deluca
Murali Krishna Cherukuri
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of DK0986393T3 publication Critical patent/DK0986393T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK98923772T 1997-05-27 1998-05-27 Anvendelse af et nitroxid eller et prodrug heraf ved profylaktisk og terapeutisk behandling af cancer DK0986393T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4772497P 1997-05-27 1997-05-27
PCT/US1998/010685 WO1998053835A1 (en) 1997-05-27 1998-05-27 The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer

Publications (1)

Publication Number Publication Date
DK0986393T3 true DK0986393T3 (da) 2004-07-05

Family

ID=21950574

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98923772T DK0986393T3 (da) 1997-05-27 1998-05-27 Anvendelse af et nitroxid eller et prodrug heraf ved profylaktisk og terapeutisk behandling af cancer

Country Status (10)

Country Link
EP (1) EP0986393B1 (da)
JP (3) JP4856294B2 (da)
AT (1) ATE262330T1 (da)
AU (1) AU746505B2 (da)
CA (1) CA2289017C (da)
DE (1) DE69822626T8 (da)
DK (1) DK0986393T3 (da)
ES (1) ES2216286T3 (da)
PT (1) PT986393E (da)
WO (1) WO1998053835A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096759A (en) * 1997-09-19 2000-08-01 Georgetown University Method for treating essential hypertension
JP2002519311A (ja) 1998-06-26 2002-07-02 ジョージタウン・ユニバーシティ・メディカル・センター 細胞死を誘発するための組成物と方法
US20040219201A1 (en) * 2001-12-06 2004-11-04 Yechezkel Barenholz Tempamine compositions and methods of use
US20070010506A1 (en) * 2003-05-29 2007-01-11 Kenneth Chang Methods of using nitroxides in conjuction with photosensitzers and sonosensitizers
JP2008528701A (ja) * 2005-02-02 2008-07-31 ミトス・ファーマシューティカルズ・インコーポレーテッド 腫瘍性疾患の治療又は予防に用いるためのニトロキシド類
WO2008109740A2 (en) * 2007-03-06 2008-09-12 Colby Pharmaceutical Company Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers
US8466130B2 (en) 2009-09-04 2013-06-18 Colby Pharmaceutical Company Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers
US8853277B2 (en) 2009-11-30 2014-10-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Nitroxide therapy for the treatment of von Hippel—Lindau disease (VHL) and renal clear cell carcinoma (RCC)
US20180078539A1 (en) 2016-03-23 2018-03-22 Louis Habash T-cell regulation in t-cell mediated diseases by reducing pathogenic function of th17 in a human subject through treatment with a nitroxide
WO2017165572A1 (en) * 2016-03-23 2017-09-28 Louis Habash Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxide
US10231959B2 (en) 2016-03-23 2019-03-19 Louis Habash Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4758580A (en) * 1985-06-26 1988-07-19 Yamanouchi Pharmaceutical Co., Ltd. Inhibiting growth of tumors with certain substituted phenoxy dimethyl alkanoic acids, esters or salts
EP0462305B1 (de) * 1990-06-21 1994-11-02 Huland, Edith, Dr. Dr. Verwendung zytokinhaltiger Aerosole und zytokinhaltige Aerosole selbst
US6605619B1 (en) * 1992-03-20 2003-08-12 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitroxides as protectors against oxidatives stress
AU4788396A (en) * 1995-02-16 1996-09-04 Children's Medical Center Corporation Inhibition of angiogenesis using interleukin-12

Also Published As

Publication number Publication date
JP2013121964A (ja) 2013-06-20
DE69822626D1 (de) 2004-04-29
CA2289017C (en) 2008-07-22
AU746505B2 (en) 2002-05-02
AU7598798A (en) 1998-12-30
EP0986393B1 (en) 2004-03-24
DE69822626T2 (de) 2004-08-12
ATE262330T1 (de) 2004-04-15
JP4856294B2 (ja) 2012-01-18
JP5270413B2 (ja) 2013-08-21
EP0986393A1 (en) 2000-03-22
WO1998053835A1 (en) 1998-12-03
CA2289017A1 (en) 1998-12-03
ES2216286T3 (es) 2004-10-16
DE69822626T8 (de) 2005-02-03
PT986393E (pt) 2004-06-30
JP2009185034A (ja) 2009-08-20
JP2002500671A (ja) 2002-01-08

Similar Documents

Publication Publication Date Title
DK0858330T3 (da) Præparater indeholdende derivater af hydroperoxyeicosatetraensyre og fremgangsmåder til anvendelse ved behandling af sygdom
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
TR199900827T2 (xx) Siklooksigenaz-2 inhibit�rlerinin neoplazinin tedavisinde ve �nlenmesinde kullan�m�.
NO943877D0 (no) Hemming av proliferasjon av glatte muskelceller og restenose
ES2295609T3 (es) Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor.
WO2001081312A3 (en) Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
DK0950057T3 (da) 3-pyridylenantiomerer og deres anvendelse som analgetika
DK0735868T3 (da) Anvendelse af ikke-steroide cyclooxygenaseinhibitorer til fremstilling af et medikament til behandling af forhøjet intrakul
DK0664708T3 (da) Metode til behandling af cancer ved kombinationsbehandling med 2'-halogenmethylidenderivater og et S-fase- eller M-fase-spe
DK0804437T3 (da) [a]-Annelerede pyrrolderivater og deres anvendelse i farmacien
MY119375A (en) Treatment of tinnitus using neuroprotective agents
DE69825154D1 (de) Pyridazinone als inhibitoren von cyclooxygenase-2
DE60039730D1 (de) Genetisch manipulierte Herpesviren zur Behandlung von Tumoren
UA41355C2 (uk) Засіб для лікування нейро-сніду
ATE360419T1 (de) Verwendung von n-substituierten pyridonen als tumornekrose-faktor alpha hemmer
BR0207316A (pt) Derivados de epotilona para o tratamento de tumores refratários
DK0986393T3 (da) Anvendelse af et nitroxid eller et prodrug heraf ved profylaktisk og terapeutisk behandling af cancer
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
GB0130677D0 (en) Medicaments and novel compounds
TR199900951T2 (xx) G���s kanserinin engellenmesi i�in y�ntemler.
ATE180669T1 (de) Verwendung von pregnanderivaten zur behandlung von tumoren
BR0110396A (pt) Métodos para prevenir e tratar alopecia induzida por quimioterapia ou radioterapia
BR0311223A (pt) Método para o uso de derivados de piranindol para tratar infecção pelo vìrus da hepatite c
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
TR200003194T2 (tr) Hastalık tedavisine mahsus sPLA2 önleyici bileşikler